CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.72−0.02 (-2.35%)
Close on Oct 19, 2026
- Market cap
- $2.68M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Creative Medical Technology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 24, 2026 | Sep 25, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2026 | Aug 31, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 28, 2026 | Jul 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 24, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 20, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 26, 2025 | Dec 31, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 19, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 26, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 31, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 27, 2025 | Oct 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 6, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 11, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 4, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Mar 19, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 19, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2025 | Mar 7, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2024 | Dec 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 19, 2024 | Nov 4, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2024 | Oct 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 19, 2024 | Jul 25, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 19, 2024 | Jun 5, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 17, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 10, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | Apr 29, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 22, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2023 | Dec 20, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 14, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 31, 2023 | Nov 3, 2023 | SEC EDGAR |